Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Accuray Incorporated Stories

2013-11-07 16:29:08

UCLA Researchers Evaluate Long-term Outcomes of More than 1,000 Patients from Multiple Institutions SUNNYVALE, Calif., Nov. 7, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today the publication of two papers stemming from a large multi-center study of CyberKnife® stereotactic body radiotherapy (SBRT) led by investigators at the University of California, Los Angeles (UCLA). The first paper, published in the September 2013 online issue of Radiotherapy &...

2013-10-14 16:24:28

SUNNYVALE, Calif., Oct. 14, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced that it will report results for its first quarter of fiscal 2014, ended September 30, 2013 on Thursday, November 7, 2013 after the market closes. A conference call to review the results will begin at 1:30 p.m. PST/4:30 p.m. EST and will be hosted by Joshua H. Levine, president and chief executive officer and Gregory Lichtwardt, executive vice president and chief financial officer....

2013-10-09 08:24:12

NEW YORK, October 9, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Analysts' Corner announced new research reports highlighting Amarin Corporation plc (NASDAQ: AMRN), Discovery Laboratories Inc. (NASDAQ: DSCO), Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL), Novavax, Inc. (NASDAQ: NVAX), and Accuray Incorporated (NASDAQ: ARAY). Today's readers may access these reports free of charge - including full price...

2013-10-03 08:30:13

Data Supports Growing Use of CyberKnife® SBRT for Prostate Cancer SUNNYVALE, Calif., Oct. 3, 2013 /PRNewswire/ -- ASTRO 2013 (Atlanta) - Accuray Incorporated (Nasdaq: ARAY) announced today that studies presented at the 55th Annual American Society for Radiation Oncology (ASTRO) Meeting in Atlanta, September 22 - 25, 2013 continue to reinforce evidence of clinical and quality of life benefits for the CyberKnife® and TomoTherapy® Systems. A variety of indications including prostate,...

2013-09-22 08:20:18

World's Largest Annual Gathering of the Radiation Oncology Community Provides Multiple Opportunities to Learn about the CyberKnife® M6(TM) Series and the TomoTherapy® H(TM) Series Systems SUNNYVALE, Calif. and ATLANTA, Sept. 22, 2013 /PRNewswire/ -- ASTRO 2013 -- Accuray Incorporated (Nasdaq: ARAY) announced today its momentum in gaining adoption for both the new CyberKnife® M6(TM) Series and TomoTherapy® H(TM) Series Systems at the 55th Annual American Society for Radiation...

2013-09-03 08:28:51

Accuray Appoints Successor SUNNYVALE, Calif., Sept. 3, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that Derek Bertocci has resigned as Senior Vice President and Chief Financial Officer of the company effective September 2, 2013. Today, Accuray has appointed Gregory Lichtwardt, executive vice president, chief financial officer, effective immediately. Mr. Bertocci is anticipated to continue in a consulting role with the Company. Mr. Lichtwardt, age 59,...

2013-09-02 08:20:46

NEW YORK, September 2, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Investors' Reports announced new research reports highlighting Endo Health Solutions Inc. (NASDAQ: ENDP), Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), Accuray Incorporated (NASDAQ: ARAY), and BioScrip Inc. (NASDAQ: BIOS). Today's readers may access these reports free of charge - including full...

2013-08-28 08:27:22

CORAL SPRINGS, Florida, August 28, 2013 /PRNewswire/ -- FinancialNewsMedia.com issues news updates for today's leading healthcare companies: Bio-Solutions Corp. (OTCQB: BISU), Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX), MannKind Corporation (NASDAQ: MNKD), Amgen (NASDAQ: AMGN) and Accuray Incorporated (NASDAQ: ARAY). Bio-Solutions Corp. (BISU): Bio-Solutions Corp. Announces National Direct Response Marketing Campaign for Type2Defense(TM). Bio-Solutions today...

2013-08-27 16:24:42

Continued Momentum in New Order Activity and Backlog Provides Guidance for Fiscal 2014 SUNNYVALE, Calif., Aug. 27, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today financial results for the fourth quarter and fiscal year ended June 30, 2013. Non-GAAP results are provided to enhance understanding of Accuray's ongoing core results of operations. Accuray announced continued strength in new orders booked in the fourth quarter and first patients treated in the...

2013-08-26 08:28:12

SUNNYVALE, Calif., Aug. 26, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced that its management will host an investor meeting on Monday, September 23, 2013 at the annual meeting of the American Society for Radiation Oncology (ASTRO) being held in Atlanta. The meeting is open to institutional investors and research analysts. Accuray Incorporated management will host a breakfast meeting, from 7:00 a.m. to 9:00 a.m. E.D.T. on Monday, September 23 at the OMNI...